Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Marimed (MRMD) Loans and Notes Receivables (2016 - 2025)

Marimed (MRMD) has disclosed Loans and Notes Receivables for 11 consecutive years, with $866000.0 as the latest value for Q4 2025.

  • Quarterly Loans and Notes Receivables rose 1565.38% to $866000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $866000.0 through Dec 2025, up 1565.38% year-over-year, with the annual reading at $866000.0 for FY2025, 1565.38% up from the prior year.
  • Loans and Notes Receivables for Q4 2025 was $866000.0 at Marimed, roughly flat from $866000.0 in the prior quarter.
  • The five-year high for Loans and Notes Receivables was $2.6 million in Q2 2023, with the low at $39000.0 in Q2 2025.
  • Average Loans and Notes Receivables over 5 years is $572576.6, with a median of $128000.0 recorded in 2021.
  • The sharpest move saw Loans and Notes Receivables soared 1976.38% in 2022, then tumbled 98.03% in 2024.
  • Over 5 years, Loans and Notes Receivables stood at $127000.0 in 2021, then skyrocketed by 1976.38% to $2.6 million in 2022, then tumbled by 98.03% to $52000.0 in 2023, then changed by 0.0% to $52000.0 in 2024, then soared by 1565.38% to $866000.0 in 2025.
  • According to Business Quant data, Loans and Notes Receivables over the past three periods came in at $866000.0, $866000.0, and $39000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.